(Q54268476)

27 May 2018

title

Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study. (English)

1 reference

27 May 2018

1 reference

4

1 reference

27 May 2018

Giacomo Laffi

11

1 reference

27 May 2018

Anna Linda Zignego

12

object named as

A L Zignego

1 reference

27 May 2018

A Piluso

1

1 reference

27 May 2018

C Giannini

2

1 reference

27 May 2018

E Fognani

3

1 reference

27 May 2018

P Caini

5

1 reference

27 May 2018

M Monti

6

1 reference

27 May 2018

A Petrarca

7

1 reference

27 May 2018

J Ranieri

8

1 reference

27 May 2018

T Urraro

9

1 reference

27 May 2018

E Triboli

10

1 reference

27 May 2018

publication date

4 December 2012

1 reference

27 May 2018

Journal of Viral Hepatitis

published in

1 reference

27 May 2018

volume

20

1 reference

27 May 2018

issue

4

1 reference

27 May 2018

page(s)

e107-14

1 reference

27 May 2018

Infection of peripheral mononuclear blood cells by hepatitis C virus

cites work

1 reference

Hepatitis C virus lymphotropism: lessons from a decade of studies.

21 January 2018

1 reference

Hepatitis C virus infection in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

Non-Hodgkin's lymphoma: possible role of hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia

21 January 2018

1 reference

Hepatitis-C-virus infection and cancer

21 January 2018

1 reference

Lymphotropic virus infection of peripheral blood mononuclear cells in B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role

21 January 2018

1 reference

Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease

21 January 2018

1 reference

Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach

21 January 2018

1 reference

Hepatitis C virus (HCV) infection: a systemic disease.

21 January 2018

1 reference

Hepatitis C virus-related lymphoproliferative disorders: an overview.

21 January 2018

1 reference

A role for hepatitis C virus infection in type II cryoglobulinemia

21 January 2018

1 reference

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

21 January 2018

1 reference

Cryoglobulinemia with vasculitis associated with hepatitis C virus infection

21 January 2018

1 reference

Extrahepatic manifestations of hepatitis C virus infection.

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

IL28B single nucleotide polymorphisms in the treatment of hepatitis C.

21 January 2018

1 reference

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

21 January 2018

1 reference

Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b.

21 January 2018

1 reference

IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection

21 January 2018

1 reference

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin.

21 January 2018

1 reference

An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response

21 January 2018

1 reference

Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline.

21 January 2018

1 reference

Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

21 January 2018

1 reference

Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection

21 January 2018

1 reference

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

21 January 2018

1 reference

Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis

21 January 2018

1 reference

Rheumatoid factors: host resistance or autoimmunity?

21 January 2018

1 reference

Rheumatoid factors: good or bad for you?

21 January 2018

1 reference

Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.

21 January 2018

1 reference

The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.

21 January 2018

1 reference

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation

21 January 2018

1 reference

Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors

21 January 2018

1 reference

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

21 January 2018

1 reference

Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas

21 January 2018

1 reference

The role of genetic markers in hepatitis C virus therapy: a major step for individualized care

21 January 2018

1 reference

Hepatitis C pharmacogenetics: state of the art in 2010.

21 January 2018

1 reference

Ethnic difference in the prevalence of monoclonal B-cell proliferation in patients affected by hepatitis C virus chronic liver disease

21 January 2018

1 reference

Endocrine manifestations of hepatitis C virus infection.

21 January 2018

1 reference

Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia.

21 January 2018

1 reference

Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia.

21 January 2018

1 reference

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JVH.12017

1 reference

27 May 2018

PubMed ID

23490377

1 reference

27 May 2018